Value Bridge — COVENANT MEDICAL CENTER
Current $-72M → Target $-57M (+$15.0M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-71.6M
Current EBITDA
$-56.6M
Target EBITDA
+$15.0M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$3.4M
Payer Mix Optimization
$8.2M
Cost to Collect Reduction
$2.7M
Clean Claim Improvement
$2.0M
Volume & Rate Growth
$13.6M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-72M to $-57M. The highest-impact lever is Volume & Rate Growth at $5.4M probability-weighted.
IC talking point: "We see $15M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $166M in equity value creation."